Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic.
Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities invo...
Main Authors: | John E McCarthy, Barry D Dewitt, Bob A Dumas, Myles T McCarthy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0245381 |
Similar Items
-
Development of Diagnostic Tests for Detection of SARS-CoV-2
by: Ngan N. T. Nguyen, et al.
Published: (2020-11-01) -
Anti-rheumatic in SARS-CoV-2: benefit or risk?
by: Francesco Ferrara
Published: (2020-04-01) -
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
by: Debra Van Egeren, et al.
Published: (2023-04-01) -
Balancing risk and benefit of SARS-CoV-2 vaccines in children
by: Michael Levin, et al.
Published: (2022-07-01) -
Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)